RenovoRx, Inc. (RNXT) Q1 2025 Earnings Call

Investor webinar replay

Replay transcript excerpt

afternoon everyone and welcome to the renovo rx q1 2025 financial and operational highlights conference call all participants will be in a listen-only mode if you need assistance please email a conference specialist by pressing the star key followed by zero after today's presentation there will be an opportunity to ask questions to ask a question you may press star and then one on your touchtone phones to withdraw your questions you may press star and two Please also note today's event is being recorded. At this time, I'd like to turn the floor over to Walter Pinto, Managing Director at KCSA Strategic Communications. Sir, please go ahead. Thank you, Operator. Good afternoon, and welcome, everyone, to the Renovo Rx first quarter 2025 conference call. I'm joined today by Renovo RACS's leadership team, including Dr. Ramta Nagar, founder and chief medical officer, Sean Bagai, chief executive officer, and Ronald Kozak, VP controller and principal accounting officer. Before we begin, I'd like to remind everyone the statements made during today's conference call may be deemed forward-looking statements within the meaning of the safe harbor of the Private Securities Litigation Reform Act of 1995 and applicable federal securities laws. and that actual results may differ materially and adversely from what is contemplated by such forward-looking statements due to a variety of substantial risks, uncertainties, and other factors. The company's forward-looking statements are based on management's current plans and assumptions and are subject to the risks and uncertainties more fully described in the company's filings with the SEC. These statements reflect management's view of current and future market conditions, including but not limited to statements regarding the company's clin...